Protagonist Therapeutics (PTGX) FCF Margin (QoQ) (2017 - 2026)
Protagonist Therapeutics (PTGX) FCF Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Protagonist Therapeutics | 8.88 Bn | 8.88 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,143.00 |
| Dec 31, 2025 | -47,936.00 |
| Sep 30, 2025 | 47,187.00 |
| Jun 30, 2025 | -95,169.00 |
| Mar 31, 2025 | 45,860.00 |
| Dec 31, 2024 | 59,460.00 |
| Sep 30, 2024 | -705,809.00 |
| Jun 30, 2024 | 645,647.00 |
| Mar 31, 2024 | -4,474.00 |
| Jun 30, 2022 | -147,357.00 |
| Mar 31, 2022 | 16,651.00 |
| Dec 31, 2021 | -4,321.00 |
| Sep 30, 2021 | 79,954.00 |
| Jun 30, 2021 | -60,413.00 |
| Mar 31, 2021 | -13,006.00 |
| Dec 31, 2020 | -21,137.00 |
| Sep 30, 2020 | 22,291.00 |
| Jun 30, 2020 | 9,066.00 |
| Mar 31, 2020 | -108,109.00 |
| Dec 31, 2019 | 97,932.00 |